NORELGESTROMIN AND ETHINYL ESTRADIOL

NORELGESTROMIN AND ETHINYL ESTRADIOL was reported 1866 times

NORELGESTROMIN AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACK OF APPLICATION SITE ROTATION 21 0.1391
1 APPLICATION SITE STREAKING 1 0.0769
2 PREGNANCY WITH CONTRACEPTIVE PATCH 12 0.0682
3 GASTROPARESIS POSTOPERATIVE 1 0.0588
4 POSTPARTUM ANXIETY 1 0.0500
5 SEXUALLY ACTIVE 1 0.0455
6 MICROSCOPIC ENTERITIS 1 0.0435
7 RETIREMENT 1 0.0400
8 ADMINISTRATION SITE SCAB 1 0.0385
9 FEAR OF PREGNANCY 1 0.0303
10 APPLICATION SITE MASS 8 0.0292
11 SPONTANEOUS RUPTURE OF MEMBRANES 1 0.0286
12 HEREDITARY ATAXIA 1 0.0286
13 APPLICATION SITE PHOTOSENSITIVITY REACTION 1 0.0270
14 APPLICATION SITE ECZEMA 2 0.0230
15 PRODUCT ADHESION ISSUE 708 0.0198
16 HUMAN CHORIONIC GONADOTROPIN ABNORMAL 1 0.0172
17 OCCUPATIONAL PROBLEM ENVIRONMENTAL 1 0.0169
18 APPLICATION SITE ODOUR 2 0.0138
19 APPLICATION SITE EXTRAVASATION 1 0.0133
20 APPLICATION SITE SCAR 15 0.0120
21 SOMATIC DYSFUNCTION 1 0.0111
22 HYDROSALPINX 1 0.0109
23 OPTIC NERVE NEOPLASM 1 0.0106
24 BIOCHEMICAL PREGNANCY 1 0.0093
25 APPLICATION SITE BRUISE 9 0.0092
26 MESENTERIC ARTERY EMBOLISM 1 0.0092
27 PROGESTERONE INCREASED 1 0.0090
28 APPLICATION SITE RASH 119 0.0086
29 APPLICATION SITE IRRITATION 105 0.0084
30 MENSTRUAL DISCOMFORT 1 0.0083
31 PERINEAL DISORDER 1 0.0083
32 APPLICATION SITE BURN 40 0.0081
33 TRANSIENT APHASIA 1 0.0076
34 PREMENSTRUAL PAIN 1 0.0076
35 APPLICATION SITE PRURITUS 167 0.0074
36 INFLAMMATORY CARCINOMA OF THE BREAST 1 0.0069
37 PORTAL VEIN OCCLUSION 1 0.0068
38 APPLICATION SITE URTICARIA 15 0.0067
39 APPLICATION SITE HYPERSENSITIVITY 8 0.0066
40 METRORRHAGIA 111 0.0065
41 APPLICATION SITE SWELLING 31 0.0062
42 BLADDER CYST 1 0.0062
43 APPLICATION SITE WOUND 1 0.0061
44 APPLICATION SITE INDURATION 1 0.0059
45 BLOOD OESTROGEN ABNORMAL 1 0.0058
46 APPLICATION SITE PERSPIRATION 1 0.0058
47 POLYMENORRHOEA 20 0.0058
48 WITHDRAWAL BLEED 4 0.0055
49 APPLICATION SITE EROSION 7 0.0054
50 APPLICATION SITE DISCOLOURATION 22 0.0054
51 VISUAL SNOW SYNDROME 1 0.0054
52 APPLICATION SITE INJURY 1 0.0053
53 BENIGN HEPATIC NEOPLASM 1 0.0050
54 HIGH RISK PREGNANCY 2 0.0049
55 PREMENSTRUAL DYSPHORIC DISORDER 1 0.0049
56 APPLICATION SITE LACERATION 2 0.0048
57 INTERMENSTRUAL BLEEDING 27 0.0048
58 PREGNANCY ON CONTRACEPTIVE 7 0.0048
59 SKIN PRESSURE MARK 1 0.0047
60 PELVIC FLOOR DYSFUNCTION 1 0.0047
61 APPLICATION SITE PAPULES 5 0.0047
62 ROCKY MOUNTAIN SPOTTED FEVER 1 0.0047
63 APPLICATION SITE SCAB 10 0.0046
64 APPLICATION SITE ERYTHEMA 121 0.0046
65 MENSTRUAL DISORDER 38 0.0046
66 APPLICATION SITE INFLAMMATION 6 0.0043
67 APPLICATION SITE HYPOAESTHESIA 1 0.0043
68 APPLICATION SITE EXFOLIATION 17 0.0041
69 APPLICATION SITE ACNE 2 0.0041
70 APPLICATION SITE WARMTH 5 0.0039
71 APPLICATION SITE VESICLES 24 0.0037
72 APPLICATION SITE REACTION 26 0.0037
73 OLIGOMENORRHOEA 8 0.0037
74 DERMAL ABSORPTION IMPAIRED 1 0.0036
75 CHONDROMALACIA 1 0.0035
76 ROTAVIRUS INFECTION 2 0.0035
77 CHEMICAL BURN 4 0.0035
78 ABDOMINAL WALL DISORDER 1 0.0034
79 BLOOD OESTROGEN INCREASED 2 0.0034
80 PHYSICAL PRODUCT LABEL ISSUE 4 0.0034
81 APPLICATION SITE PAIN 73 0.0033
82 LACK OF ADMINISTRATION SITE ROTATION 1 0.0033
83 APPLICATION SITE DRYNESS 11 0.0032
84 APPLICATION SITE DERMATITIS 3 0.0032
85 MENSTRUATION NORMAL 1 0.0030
86 HEMIPLEGIC MIGRAINE 1 0.0029
87 ASTHMA EXERCISE INDUCED 1 0.0029
88 IMPLANT SITE RASH 1 0.0028
89 BITE 2 0.0028
90 APPLICATION SITE PUSTULES 1 0.0027
91 IMPLANT SITE IRRITATION 1 0.0026
92 MESENTERIC ARTERY THROMBOSIS 1 0.0026
93 LIPID METABOLISM DISORDER 1 0.0026
94 APPLICATION SITE DISCHARGE 3 0.0026
95 HAEMORRHAGIC CYST 1 0.0026
96 APPLICATION SITE HAEMORRHAGE 7 0.0026
97 DELUSIONAL PERCEPTION 1 0.0024
98 APPLICATION SITE PARAESTHESIA 3 0.0023
99 FIBROADENOMA OF BREAST 1 0.0022
100 IMPLANT SITE PRURITUS 2 0.0022
101 CATHETER SITE RASH 1 0.0022
102 PELVIC INFECTION 1 0.0022
103 MANUFACTURING ISSUE 1 0.0022
104 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
105 WRONG SCHEDULE 2 0.0021
106 MENOMETRORRHAGIA 4 0.0021
107 DERMATITIS INFECTED 1 0.0020
108 HYPERMOBILITY SYNDROME 1 0.0020
109 APPLICATION SITE INFECTION 1 0.0020
110 UTERINE PAIN 2 0.0019
111 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
112 PRODUCT RESIDUE PRESENT 10 0.0019
113 MORNING SICKNESS 1 0.0018
114 SUSPECTED PRODUCT TAMPERING 1 0.0018
115 ENCEPHALOMALACIA 1 0.0018
116 DYSMENORRHOEA 23 0.0017
117 IRREGULAR BREATHING 1 0.0017
118 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 344 0.0017
119 UTERINE SPASM 3 0.0016
120 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 1 0.0016
121 VULVAL DISORDER 1 0.0015
122 PREMENSTRUAL SYNDROME 2 0.0015
123 HORMONE LEVEL ABNORMAL 7 0.0014
124 BLOOD OESTROGEN DECREASED 1 0.0014
125 FLUID IMBALANCE 1 0.0014
126 ANTIBODY TEST ABNORMAL 1 0.0014
127 MENORRHAGIA 27 0.0014
128 SUPPRESSED LACTATION 1 0.0013
129 RUBBER SENSITIVITY 2 0.0013
130 MEDICAL DEVICE SITE DISCOMFORT 1 0.0012
131 CHEMICAL INJURY 1 0.0012
132 HEAVY MENSTRUAL BLEEDING 11 0.0012
133 SEIZURE CLUSTER 1 0.0012
134 MENSTRUATION IRREGULAR 32 0.0012
135 INTENTIONAL DEVICE USE ISSUE 1 0.0012
136 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
137 APPLICATION SITE DISCOMFORT 2 0.0011
138 SELECTIVE EATING DISORDER 1 0.0011
139 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
140 PRODUCT APPEARANCE CONFUSION 1 0.0011
141 PROGESTERONE RECEPTOR ASSAY POSITIVE 1 0.0011
142 DERMATITIS CONTACT 12 0.0011
143 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
144 VAGINAL DISORDER 1 0.0010
145 EMBOLISM VENOUS 3 0.0010
146 IMPLANT SITE SWELLING 1 0.0010
147 BREAST DISCOMFORT 1 0.0010
148 IMPLANT SITE ERYTHEMA 1 0.0010
149 BREAST TENDERNESS 7 0.0009
150 REACTION TO DRUG EXCIPIENTS 2 0.0009
151 HAEMORRHAGIC DISORDER 1 0.0009
152 BENIGN NEOPLASM 1 0.0009
153 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
154 VAGINAL HAEMORRHAGE 37 0.0009
155 SKIN WEEPING 3 0.0008
156 MENSTRUATION DELAYED 9 0.0008
157 HYPERAESTHESIA TEETH 1 0.0008
158 CHEMICAL BURN OF SKIN 2 0.0008
159 MOOD SWINGS 25 0.0008
160 ADNEXA UTERI PAIN 1 0.0008
161 WISDOM TEETH REMOVAL 1 0.0008
162 PRODUCT LABEL ISSUE 5 0.0007
163 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
164 PRODUCT QUALITY ISSUE 99 0.0007
165 CATAPLEXY 1 0.0007
166 GLUTEN SENSITIVITY 1 0.0007
167 SMEAR CERVIX ABNORMAL 1 0.0007
168 SLEEP PARALYSIS 1 0.0007
169 GENERALISED ANXIETY DISORDER 1 0.0007
170 ANKLE OPERATION 1 0.0007
171 TOBACCO USER 1 0.0007
172 SKIN STRIAE 1 0.0007
173 ASTIGMATISM 1 0.0007
174 BREAST PAIN 7 0.0007
175 ECTOPIC PREGNANCY 2 0.0006
176 INFERTILITY FEMALE 1 0.0006
177 PRODUCT SUBSTITUTION ISSUE 37 0.0006
178 BACTERIAL VAGINOSIS 1 0.0006
179 INAPPROPRIATE AFFECT 1 0.0006
180 VULVOVAGINAL PAIN 3 0.0006
181 VEIN RUPTURE 1 0.0006
182 EXPOSURE TO SARS-COV-2 1 0.0006
183 ENTERITIS INFECTIOUS 1 0.0006
184 DEVICE ADHESION ISSUE 9 0.0006
185 LACK OF INJECTION SITE ROTATION 1 0.0006
186 INFUSION SITE DISCHARGE 1 0.0006
187 PRODUCT COMMUNICATION ISSUE 5 0.0006
188 TERMINAL INSOMNIA 1 0.0006
189 BREAST CYST 1 0.0006
190 DEVICE PLACEMENT ISSUE 2 0.0006
191 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
192 UTERINE POLYP 1 0.0006
193 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
194 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
195 VULVOVAGINAL SWELLING 1 0.0005
196 HYPERTRICHOSIS 1 0.0005
197 SUNBURN 4 0.0005
198 PARANASAL SINUS DISCOMFORT 2 0.0005
199 MOTION SICKNESS 1 0.0005
200 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
201 SKIN ODOUR ABNORMAL 2 0.0005
202 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
203 EAR HAEMORRHAGE 1 0.0005
204 SELF-INJURIOUS IDEATION 2 0.0005
205 DEVICE MATERIAL ISSUE 1 0.0005
206 NEUROGENIC BLADDER 1 0.0005
207 EYE CONTUSION 1 0.0005
208 INFUSION SITE BRUISING 1 0.0005
209 GASTRIC BYPASS 1 0.0005
210 CERVICAL DYSPLASIA 1 0.0005
211 AMENORRHOEA 8 0.0005
212 DANDRUFF 1 0.0005
213 CHRONIC GASTRITIS 1 0.0004
214 PUSTULE 1 0.0004
215 MYOPIA 1 0.0004
216 ENDOMETRIOSIS 2 0.0004
217 WEIGHT ABNORMAL 1 0.0004
218 WRONG DOSE 1 0.0004
219 LYMPHADENITIS 1 0.0004
220 BLINDNESS TRANSIENT 3 0.0004
221 VENTRICULAR HYPERTROPHY 1 0.0004
222 VAGINAL DISCHARGE 4 0.0004
223 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
224 PRODUCT COLOUR ISSUE 2 0.0004
225 DRUG TITRATION ERROR 1 0.0004
226 PRODUCT DOSE OMISSION 25 0.0004
227 PROTEIN TOTAL INCREASED 1 0.0004
228 PRODUCT SIZE ISSUE 2 0.0004
229 SKIN DISCOMFORT 1 0.0004
230 SKIN WRINKLING 1 0.0004
231 HYPOMENORRHOEA 1 0.0004
232 TRICHORRHEXIS 1 0.0004
233 PRODUCT LEAKAGE 2 0.0004
234 CEREBRAL THROMBOSIS 1 0.0004
235 VITAMIN B12 DECREASED 1 0.0003
236 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
237 NECK INJURY 1 0.0003
238 ACNE CYSTIC 1 0.0003
239 MEDICAL DEVICE DISCOMFORT 1 0.0003
240 BRAIN DEATH 1 0.0003
241 EYELIDS PRURITUS 1 0.0003
242 FLANK PAIN 3 0.0003
243 ABDOMINAL ADHESIONS 1 0.0003
244 PRODUCT PACKAGING ISSUE 3 0.0003
245 VULVOVAGINAL DRYNESS 1 0.0003
246 HEPATIC NEOPLASM 1 0.0003
247 COELIAC DISEASE 3 0.0003
248 SKIN IRRITATION 14 0.0003
249 BREAST ENLARGEMENT 1 0.0003
250 NEAR DEATH EXPERIENCE 1 0.0003
251 ANXIETY DISORDER 1 0.0003
252 PLANTAR FASCIITIS 1 0.0003
253 TONGUE ULCERATION 1 0.0003
254 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
255 CAROTID ARTERY STENOSIS 1 0.0003
256 SKIN REACTION 4 0.0003
257 DEPRESSIVE SYMPTOM 1 0.0003
258 APPENDICECTOMY 1 0.0003
259 FRUSTRATION 1 0.0003
260 IMPAIRED QUALITY OF LIFE 4 0.0003
261 PHARYNGITIS STREPTOCOCCAL 3 0.0003
262 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
263 CAROTID ARTERY OCCLUSION 1 0.0003
264 MAJOR DEPRESSION 2 0.0003
265 UTERINE LEIOMYOMA 2 0.0003
266 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
267 SENSITIVE SKIN 2 0.0003
268 PAROSMIA 2 0.0003
269 CATHETER SITE INFECTION 1 0.0003
270 LOSS OF CONTROL OF LEGS 1 0.0003
271 OESOPHAGEAL DISORDER 1 0.0003
272 OFF LABEL USE 226 0.0003
273 MOOD ALTERED 7 0.0003
274 VENOUS THROMBOSIS 1 0.0003
275 FURUNCLE 2 0.0003
276 CEREBRAL ATROPHY 1 0.0003
277 NO ADVERSE EVENT 45 0.0002
278 PRODUCT PHYSICAL ISSUE 5 0.0002
279 ENURESIS 1 0.0002
280 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
281 PERIPHERAL VENOUS DISEASE 1 0.0002
282 PHOTOSENSITIVITY REACTION 4 0.0002
283 MIGRAINE 23 0.0002
284 EMBOLISM 2 0.0002
285 SLEEP TERROR 1 0.0002
286 INTESTINAL STENOSIS 1 0.0002
287 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
288 THROAT CANCER 1 0.0002
289 HEPATIC PAIN 1 0.0002
290 PRODUCT DISPENSING ISSUE 1 0.0002
291 ONYCHOMYCOSIS 1 0.0002
292 INTENTIONAL DEVICE MISUSE 1 0.0002
293 VULVOVAGINAL DISCOMFORT 1 0.0002
294 ABORTION SPONTANEOUS 9 0.0002
295 ACNE 17 0.0002
296 ILEUS PARALYTIC 1 0.0002
297 FACIAL PAIN 2 0.0002
298 IMPLANT SITE PAIN 1 0.0002
299 VASCULAR DEVICE INFECTION 1 0.0002
300 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
301 DYSPAREUNIA 1 0.0002
302 HUNGER 3 0.0002
303 SKIN TIGHTNESS 1 0.0002
304 ABDOMINAL DISTENSION 22 0.0002
305 MEDICATION RESIDUE PRESENT 1 0.0002
306 INCREASED APPETITE 4 0.0002
307 ENTEROCOCCAL INFECTION 1 0.0002
308 RASH VESICULAR 1 0.0002
309 DIZZINESS POSTURAL 2 0.0002
310 PHARYNGEAL SWELLING 2 0.0002
311 COMPLICATION OF DEVICE INSERTION 4 0.0002
312 INJECTION SITE INFLAMMATION 1 0.0002
313 PETIT MAL EPILEPSY 1 0.0002
314 WEIGHT FLUCTUATION 2 0.0002
315 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
316 SCRATCH 2 0.0002
317 INTESTINAL RESECTION 1 0.0002
318 BRUXISM 1 0.0002
319 HIP SURGERY 1 0.0002
320 BLOOD GLUCOSE FLUCTUATION 2 0.0002
321 ASTHENOPIA 1 0.0002
322 HAEMORRHAGE 19 0.0002
323 CYSTIC FIBROSIS 1 0.0002
324 STREPTOCOCCAL INFECTION 1 0.0002
325 INTESTINAL PERFORATION 2 0.0002
326 CHOLECYSTITIS ACUTE 1 0.0002
327 SKIN DISCOLOURATION 8 0.0002
328 THROMBOSIS 14 0.0002
329 HYPERTRIGLYCERIDAEMIA 1 0.0002
330 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
331 URINE ODOUR ABNORMAL 1 0.0002
332 DECREASED INTEREST 1 0.0002
333 DRUG DOSE OMISSION 28 0.0002
334 DRUG EFFECT DECREASED 9 0.0002
335 TYPE 1 DIABETES MELLITUS 1 0.0002
336 HEPATITIS B 1 0.0002
337 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
338 DERMATITIS ACNEIFORM 1 0.0002
339 VULVOVAGINAL BURNING SENSATION 1 0.0002
340 EMOTIONAL DISORDER 5 0.0002
341 PRE-EXISTING CONDITION IMPROVED 1 0.0002
342 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
343 INFUSION SITE SWELLING 1 0.0002
344 BLEPHAROSPASM 1 0.0002
345 PULMONARY EMBOLISM 15 0.0002
346 THERAPEUTIC RESPONSE CHANGED 1 0.0002
347 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
348 SCREAMING 1 0.0002
349 POST PROCEDURAL COMPLICATION 3 0.0002
350 SOMNAMBULISM 1 0.0002
351 PRODUCT FORMULATION ISSUE 1 0.0002
352 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
353 SKIN MASS 1 0.0001
354 POST-TRAUMATIC STRESS DISORDER 1 0.0001
355 POSTOPERATIVE WOUND INFECTION 1 0.0001
356 FEEDING DISORDER 3 0.0001
357 THROAT TIGHTNESS 4 0.0001
358 ANGER 5 0.0001
359 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
360 IMPAIRED GASTRIC EMPTYING 2 0.0001
361 PRODUCT DOSE OMISSION ISSUE 43 0.0001
362 DROOLING 1 0.0001
363 PAPULE 1 0.0001
364 PANIC REACTION 1 0.0001
365 WEIGHT INCREASED 31 0.0001
366 PRODUCT USE ISSUE 26 0.0001
367 PRODUCT PRESCRIBING ISSUE 3 0.0001
368 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
369 ORAL DISORDER 1 0.0001
370 ARTHROPOD BITE 1 0.0001
371 FEELING DRUNK 1 0.0001
372 ECZEMA 7 0.0001
373 IRRITABILITY 8 0.0001
374 DERMATITIS ATOPIC 7 0.0001
375 TROPONIN INCREASED 1 0.0001
376 URTICARIA 22 0.0001
377 ABDOMINAL PAIN UPPER 27 0.0001
378 INSURANCE ISSUE 2 0.0001
379 MUSCLE SPASMS 24 0.0001
380 BOWEL MOVEMENT IRREGULARITY 1 0.0001
381 LIMB DISCOMFORT 4 0.0001
382 CONCUSSION 1 0.0001
383 ABDOMINAL PAIN 30 0.0001
384 BRAIN FOG 2 0.0001
385 ILLNESS 13 0.0001
386 RENAL CYST 1 0.0001
387 PRODUCT STORAGE ERROR 11 0.0001
388 RASH ERYTHEMATOUS 6 0.0001
389 NIGHT SWEATS 4 0.0001
390 RHINITIS 1 0.0001
391 FRUSTRATION TOLERANCE DECREASED 1 0.0001
392 PRESYNCOPE 3 0.0001
393 HYPERAESTHESIA 1 0.0001
394 ESCHERICHIA INFECTION 1 0.0001
395 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
396 EXPIRED PRODUCT ADMINISTERED 4 0.0001
397 VIRAL INFECTION 4 0.0001
398 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
399 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
400 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
401 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
402 SKIN HYPERPIGMENTATION 1 0.0001
403 PSYCHOLOGICAL TRAUMA 1 0.0001
404 HYSTERECTOMY 1 0.0001
405 BURNING SENSATION 8 0.0001
406 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
407 GASTROINTESTINAL INFECTION 1 0.0001
408 LOSS OF LIBIDO 1 0.0001
409 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
410 CRYING 4 0.0001
411 PANIC ATTACK 4 0.0001
412 BRAIN NEOPLASM 1 0.0001
413 RASH 47 0.0001
414 PERSONALITY CHANGE 1 0.0001
415 MIDDLE INSOMNIA 2 0.0001
416 DEFORMITY 1 0.0001
417 BLISTER 6 0.0001
418 SKIN EXFOLIATION 9 0.0001
419 ABORTION INDUCED 1 0.0001
420 BLOOD URINE PRESENT 2 0.0001
421 INTENTIONAL DOSE OMISSION 3 0.0001
422 SLEEP APNOEA SYNDROME 2 0.0001
423 AFFECT LABILITY 1 0.0001
424 HERNIA 2 0.0001
425 VITAMIN D DEFICIENCY 1 0.0001
426 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
427 HYPERSENSITIVITY 19 0.0001
428 SURGERY 6 0.0001
429 SKIN FISSURES 2 0.0001
430 DISABILITY 2 0.0001
431 BRAIN INJURY 1 0.0001
432 PRODUCT ADMINISTRATION ERROR 2 0.0001
433 DRY THROAT 1 0.0001
434 DISCOMFORT 6 0.0001
435 THERAPY INTERRUPTED 7 0.0001
436 INJECTION SITE RASH 3 0.0001
437 EUPHORIC MOOD 1 0.0001
438 INITIAL INSOMNIA 1 0.0001
439 EAR DISCOMFORT 1 0.0001
440 TEMPERATURE INTOLERANCE 1 0.0001
441 CYSTITIS 3 0.0001
442 HEADACHE 59 0.0001
443 IMPAIRED WORK ABILITY 2 0.0001
444 BODY HEIGHT DECREASED 1 0.0001
445 IRRITABLE BOWEL SYNDROME 2 0.0001
446 PRURITUS GENERALISED 2 0.0001
447 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
448 DEPRESSION 21 0.0001
449 BIPOLAR DISORDER 1 0.0001
450 BACK INJURY 1 0.0001
451 TREATMENT NONCOMPLIANCE 5 0.0001
452 STAPHYLOCOCCAL INFECTION 3 0.0001
453 FUNGAL INFECTION 3 0.0001
454 NERVE INJURY 1 0.0001
455 HYPERTENSIVE CRISIS 1 0.0001
456 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
457 ADVERSE DRUG REACTION 8 0.0001
458 REBOUND EFFECT 1 0.0001
459 FLATULENCE 5 0.0001
460 ANXIETY 25 0.0001
461 PRODUCT AVAILABILITY ISSUE 2 0.0001
462 SCAB 1 0.0001
463 INTERNAL HAEMORRHAGE 1 0.0001
464 SUICIDAL IDEATION 8 0.0001
465 INJECTION SITE REACTION 6 0.0001
466 MUSCLE TWITCHING 2 0.0001
467 NIGHTMARE 3 0.0001
468 SEIZURE 10 0.0001
469 NAUSEA 68 0.0001
470 CAESAREAN SECTION 1 0.0001
471 SWELLING 8 0.0001
472 SEXUAL DYSFUNCTION 1 0.0001
473 MUSCLE RIGIDITY 1 0.0001
474 FEELING HOT 5 0.0001
475 INJECTION SITE URTICARIA 2 0.0001
476 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
477 SMALL INTESTINAL OBSTRUCTION 1 0.0001
478 GENERALISED OEDEMA 1 0.0001
479 HYPOAESTHESIA 12 0.0001
480 INTENTIONAL PRODUCT MISUSE 7 0.0001
481 ASTHMA 9 0.0001
482 HOT FLUSH 6 0.0001
483 BRAIN OEDEMA 1 0.0001
484 PRODUCT COMPLAINT 2 0.0001
485 FLUID RETENTION 4 0.0001
486 GASTROINTESTINAL DISORDER 7 0.0001
487 RASH GENERALISED 2 0.0001
488 IMMUNE SYSTEM DISORDER 1 0.0001
489 ABNORMAL BEHAVIOUR 3 0.0001
490 QUALITY OF LIFE DECREASED 1 0.0001
491 SINUS CONGESTION 1 0.0001
492 PSORIATIC ARTHROPATHY 3 0.0001
493 DEVICE OCCLUSION 1 0.0001
494 VOMITING 33 0.0001
495 PARALYSIS 1 0.0001
496 HYPERSOMNIA 2 0.0001
497 HYPOKINESIA 1 0.0001
498 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
499 SKIN HAEMORRHAGE 1 0.0001
500 ECONOMIC PROBLEM 1 0.0001
501 THERAPEUTIC RESPONSE DECREASED 4 0.0001
502 ABDOMINAL DISCOMFORT 11 0.0001
503 DRUG DISPENSING ERROR 1 0.0001
504 TINNITUS 3 0.0001
505 PRURITUS 25 0.0001
506 DEVICE RELATED INFECTION 1 0.0001
507 TENDONITIS 1 0.0001
508 DELUSION 1 0.0001
509 EXPOSURE DURING PREGNANCY 4 0.0001
510 MENINGIOMA 1 0.0001
511 PRODUCT USE COMPLAINT 1 0.0001
512 PREMATURE DELIVERY 1 0.0001
513 OBESITY 1 0.0001
514 SCIATICA 1 0.0001
515 LOSS OF CONSCIOUSNESS 8 0.0001
516 HYPERHIDROSIS 8 0.0001
517 MUSCLE TIGHTNESS 1 0.0001
518 DEEP VEIN THROMBOSIS 4 0.0001
519 BACK DISORDER 1 0.0001
520 METASTASES TO BONE 1 0.0001
521 EYE DISORDER 2 0.0001
522 MANIA 1 0.0001
523 HEART RATE INCREASED 6 0.0001
524 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
525 LIP SWELLING 2 0.0001
526 SKIN DISORDER 2 0.0001
527 AGGRESSION 3 0.0001
528 FACE OEDEMA 1 0.0001
529 SINUSITIS 6 0.0001
530 THERAPY CESSATION 3 0.0001
531 FEELING ABNORMAL 14 0.0001
532 PERIPHERAL SWELLING 9 0.0001
533 SCAR 1 0.0001
534 DIZZINESS 29 0.0001
535 LOCAL SWELLING 1 0.0001
536 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
537 DEPRESSED MOOD 3 0.0001
538 COLD SWEAT 1 0.0001
539 SLEEP DISORDER 4 0.0001
540 DRUG ERUPTION 1 0.0001
541 TACHYCARDIA 5 0.0001
542 GALLBLADDER DISORDER 1 0.0001
543 THIRST 1 0.0001
544 CEREBRAL HAEMORRHAGE 2 0.0001
545 DISTURBANCE IN ATTENTION 3 0.0001
546 GASTROENTERITIS VIRAL 1 0.0001
547 COMPLICATION OF DEVICE REMOVAL 1 0.0001
548 DRUG EFFECT INCOMPLETE 2 0.0001
549 PELVIC PAIN 1 0.0001
550 RESTLESS LEGS SYNDROME 1 0.0001
551 HAEMATOCHEZIA 3 0.0001
552 PAIN IN EXTREMITY 16 0.0001
553 ANAPHYLACTIC REACTION 3 0.0001
554 ADVERSE EVENT 5 0.0001
555 BLOOD GLUCOSE ABNORMAL 1 0.0001
556 INJECTION SITE MASS 2 0.0001
557 INFLUENZA 6 0.0001
558 HEPATIC STEATOSIS 1 0.0001
559 THINKING ABNORMAL 1 0.0001
560 UNEVALUABLE EVENT 4 0.0001
561 DRY SKIN 7 0.0001
562 DRUG PRESCRIBING ERROR 1 0.0001
563 ERUCTATION 1 0.0001
564 DYSTONIA 1 0.0001
565 EAR PAIN 1 0.0001
566 KIDNEY INFECTION 1 0.0001
567 MEMORY IMPAIRMENT 7 0.0001
568 ALOPECIA 10 0.0001
569 DRUG INEFFECTIVE 67 0.0001
570 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
571 SINUS DISORDER 1 0.0001
572 BLOOD PRESSURE ABNORMAL 1 0.0001
573 SYNCOPE 5 0.0000
574 PREGNANCY 1 0.0000
575 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
576 VERTIGO 3 0.0000
577 BLINDNESS 2 0.0000
578 BODY TEMPERATURE INCREASED 1 0.0000
579 PAIN 30 0.0000
580 ERYTHEMA 10 0.0000
581 INJECTION SITE WARMTH 1 0.0000
582 PULMONARY HYPERTENSION 1 0.0000
583 POLLAKIURIA 2 0.0000
584 DERMATITIS 1 0.0000
585 FATIGUE 37 0.0000
586 BACK PAIN 11 0.0000
587 RETCHING 1 0.0000
588 LIVER FUNCTION TEST INCREASED 1 0.0000
589 POOR QUALITY SLEEP 1 0.0000
590 DEVICE LEAKAGE 2 0.0000
591 DEVICE DISLOCATION 2 0.0000
592 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
593 SNEEZING 1 0.0000
594 CHROMATURIA 1 0.0000
595 INCORRECT DOSE ADMINISTERED 10 0.0000
596 VISION BLURRED 6 0.0000
597 OCULAR HYPERAEMIA 2 0.0000
598 DISEASE RECURRENCE 2 0.0000
599 PRODUCT PRESCRIBING ERROR 1 0.0000
600 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
601 INFECTION 6 0.0000
602 FIBROMYALGIA 1 0.0000
603 NEURALGIA 1 0.0000
604 UNDERDOSE 3 0.0000
605 HALLUCINATION 3 0.0000
606 ABDOMINAL PAIN LOWER 1 0.0000
607 CARDIOVASCULAR DISORDER 1 0.0000
608 HYPOPHAGIA 1 0.0000
609 ANAPHYLACTIC SHOCK 1 0.0000
610 RESPIRATORY TRACT INFECTION 1 0.0000
611 SPEECH DISORDER 2 0.0000
612 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
613 PARAESTHESIA 6 0.0000
614 JOINT STIFFNESS 1 0.0000
615 GASTRITIS 1 0.0000
616 HYPERTENSION 8 0.0000
617 EAR INFECTION 1 0.0000
618 DEHYDRATION 5 0.0000
619 JAUNDICE 1 0.0000
620 PAIN OF SKIN 1 0.0000
621 BLOOD BILIRUBIN INCREASED 1 0.0000
622 MALAISE 16 0.0000
623 RESPIRATORY ARREST 1 0.0000
624 ABNORMAL DREAMS 1 0.0000
625 TREATMENT FAILURE 3 0.0000
626 MEDICATION ERROR 2 0.0000
627 FEELING COLD 1 0.0000
628 HAEMOPTYSIS 1 0.0000
629 NECK PAIN 2 0.0000
630 MUSCULAR WEAKNESS 4 0.0000
631 URINARY TRACT INFECTION 6 0.0000
632 BALANCE DISORDER 3 0.0000
633 DECREASED APPETITE 8 0.0000
634 LIVER FUNCTION TEST ABNORMAL 1 0.0000
635 DYSSTASIA 1 0.0000
636 MUSCULOSKELETAL STIFFNESS 3 0.0000
637 COVID-19 6 0.0000
638 PALPITATIONS 4 0.0000
639 NASAL CONGESTION 2 0.0000
640 ACUTE MYOCARDIAL INFARCTION 1 0.0000
641 LABORATORY TEST ABNORMAL 1 0.0000
642 PSYCHOTIC DISORDER 1 0.0000
643 URINARY INCONTINENCE 1 0.0000
644 RENAL INJURY 1 0.0000
645 BLOOD POTASSIUM DECREASED 1 0.0000
646 DRUG ADMINISTRATION ERROR 1 0.0000
647 NASOPHARYNGITIS 6 0.0000
648 OROPHARYNGEAL PAIN 3 0.0000
649 WEIGHT DECREASED 9 0.0000
650 NERVOUS SYSTEM DISORDER 1 0.0000
651 HYPOTHYROIDISM 1 0.0000
652 MOVEMENT DISORDER 1 0.0000
653 DIARRHOEA 20 0.0000
654 DEVICE EXPULSION 2 0.0000
655 AMNESIA 2 0.0000
656 SWELLING FACE 2 0.0000
657 DYSPEPSIA 3 0.0000
658 INSOMNIA 8 0.0000
659 EYE PRURITUS 1 0.0000
660 TYPE 2 DIABETES MELLITUS 1 0.0000
661 CONDITION AGGRAVATED 9 0.0000
662 HEPATIC ENZYME INCREASED 2 0.0000
663 CHEST DISCOMFORT 3 0.0000
664 DELIRIUM 1 0.0000
665 RASH MACULAR 1 0.0000
666 HEART RATE DECREASED 1 0.0000
667 LYMPHADENOPATHY 1 0.0000
668 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
669 RESTLESSNESS 1 0.0000
670 AGITATION 2 0.0000
671 CHEST PAIN 5 0.0000
672 EYE SWELLING 1 0.0000
673 DYSPNOEA EXERTIONAL 1 0.0000
674 GAIT DISTURBANCE 5 0.0000
675 CHILLS 3 0.0000
676 DISORIENTATION 1 0.0000
677 INJECTION SITE HAEMORRHAGE 2 0.0000
678 JOINT SWELLING 3 0.0000
679 SOMNOLENCE 5 0.0000
680 EXTRA DOSE ADMINISTERED 1 0.0000
681 DEVICE BREAKAGE 1 0.0000
682 DYSKINESIA 1 0.0000
683 INFLUENZA LIKE ILLNESS 2 0.0000
684 VISUAL IMPAIRMENT 3 0.0000
685 ROAD TRAFFIC ACCIDENT 1 0.0000
686 WITHDRAWAL SYNDROME 1 0.0000
687 CEREBROVASCULAR ACCIDENT 4 0.0000
688 HYPOACUSIS 1 0.0000
689 MENTAL DISORDER 1 0.0000
690 DYSPNOEA 13 0.0000
691 CONSTIPATION 5 0.0000
692 INJECTION SITE PAIN 7 0.0000
693 LIVER DISORDER 1 0.0000
694 COLITIS ULCERATIVE 1 0.0000
695 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
696 THROAT IRRITATION 1 0.0000
697 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
698 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
699 COGNITIVE DISORDER 1 0.0000
700 CARDIAC DISORDER 2 0.0000
701 DYSPHAGIA 2 0.0000
702 NEUROPATHY PERIPHERAL 2 0.0000
703 LUNG DISORDER 1 0.0000
704 PYREXIA 7 0.0000
705 CELLULITIS 1 0.0000
706 FLUSHING 2 0.0000
707 HOSPITALISATION 3 0.0000
708 INFLAMMATION 1 0.0000
709 ARTHRALGIA 8 0.0000
710 NERVOUSNESS 1 0.0000
711 PANCREATITIS 1 0.0000
712 ASTHENIA 7 0.0000
713 RASH PRURITIC 1 0.0000
714 SEPSIS 2 0.0000
715 OXYGEN SATURATION DECREASED 1 0.0000
716 EYE PAIN 1 0.0000
717 HERPES ZOSTER 1 0.0000
718 LETHARGY 1 0.0000
719 EYE IRRITATION 1 0.0000
720 DYSPHONIA 1 0.0000
721 WHEEZING 1 0.0000
722 ILL-DEFINED DISORDER 1 0.0000
723 INJECTION SITE ERYTHEMA 2 0.0000
724 RHINORRHOEA 1 0.0000
725 PSORIASIS 2 0.0000
726 DEVICE DIFFICULT TO USE 1 0.0000
727 INFUSION RELATED REACTION 1 0.0000
728 BLOOD PRESSURE DECREASED 1 0.0000
729 INJECTION SITE PRURITUS 1 0.0000
730 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
731 COUGH 4 0.0000
732 INJURY 1 0.0000
733 MOBILITY DECREASED 1 0.0000
734 BRONCHITIS 1 0.0000
735 DYSGEUSIA 1 0.0000
736 INJECTION SITE SWELLING 1 0.0000
737 ARTHRITIS 1 0.0000
738 INJECTION SITE BRUISING 1 0.0000
739 CARDIAC FAILURE 1 0.0000
740 PNEUMONIA 4 0.0000
741 DRY MOUTH 1 0.0000
742 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
743 TREMOR 2 0.0000
744 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
745 MYALGIA 2 0.0000
746 DRUG WITHDRAWAL SYNDROME 1 0.0000
747 DEVICE ISSUE 1 0.0000
748 ANAEMIA 2 0.0000
749 CONTUSION 1 0.0000
750 DRUG INTOLERANCE 1 0.0000
751 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
752 DISEASE PROGRESSION 1 0.0000
753 EMOTIONAL DISTRESS 1 0.0000
754 BLOOD PRESSURE INCREASED 1 0.0000
755 DRUG INTERACTION 1 0.0000
756 CONFUSIONAL STATE 1 0.0000
757 FALL 2 0.0000
758 MYOCARDIAL INFARCTION 1 0.0000
759 HYPOTENSION 1 0.0000
760 DEATH 3 0.0000